DAVID GRANOVSKY

Archive for March, 2012|Monthly archive page

Court won’t reconsider bone marrow payments ruling

In BUSINESS OF STEM CELLS on March 31, 2012 at 3:38 am

Previously, you could not compensate someone for a bone marrow donation“donating bone marrow was classified the same as donating a kidney or any other organ, and payments were forbidden, punished by jail time.”

Now, bone marrow donation is so simple, it no longer resembles organ donation“the process of donating bone marrow [is] nearly identical to giving blood plasma and doesn’t amount to an organ transplant.”

So, you can get paid for a bone marrow donation -“bone marrow donors [can] be paid for their donations like blood donors.”

Many believe this is a very positive move and will encourage more donations.

bone marrow is FULL of stem cells :)

http://www.topnews.in/health/files/bone-marrow.jpg

Court won’t reconsider bone marrow payments ruling

Posted: 6:48pm on Mar 27, 2012; Modified: 9:27pm on Mar 27, 2012

A federal appeals court on Tuesday declined to reconsider a ruling that allows bone marrow donors to be paid for their donations like blood donors.

In December, the 9th U.S. Circuit Court of Appeals shook up the organ transplant community when it overturned the criminality of paying bone marrow donors. Previously, donating bone marrow was classified the same as donating a kidney or any other organ, and payments were forbidden, punished by jail time.

But the court said a technological breakthrough makes the process of donating bone marrow nearly identical to giving blood plasma and doesn’t amount to an organ transplant.

On Tuesday, the 9th Circuit declined the Obama administration’s request to reconsider the ruling. Several organizations and activisits in the organ-donation community have urged the administration to fight the ruling.

The administration now has 90 days to petition the U.S. Supreme Court.

Department of Justice spokesman Charles Miller said the administration is reviewing its options.

The nonprofit patient advocacy group Institute for Justice called the original ruling a “major national shift in bone marrow donation policy” and said payments will encourage more donations.

SAN FRANCISCO: Court won’t reconsider bone marrow payments ruling | Health | Macon.com.

 

 

New Transplant Method May Allow Kidney Recipients to Live Drug Free » Blog Archive » Critical Mass

In ALL ARTICLES on March 28, 2012 at 7:10 pm
New Transplant Method May Allow Kidney Recipients to Live Drug Free

New ongoing research published March 7 in the journal Science Translational Medicine suggests organ transplant recipients may not require anti-rejection medication in the future thanks to the power of stem cells, which may prove to be able to be manipulated in mismatched kidney donor and recipient pairs to allow for successful transplantation without immunosuppressive drugs.

Northwestern Medicine® and University of Louisville researchers are partnering on a clinical trial to study the use of donor stem cell infusions that have been specially engineered to “trick” the recipients’ immune system into thinking the donated organ is part of the patient’s natural self, thus gradually eliminating or reducing the need for anti-rejection medication.

“The preliminary results from this ongoing study are exciting and may have a major impact on organ transplantation in the future,” said Joseph Leventhal, MD, PhD, transplant surgeon at Northwestern Memorial Hospital and associate professor of surgery and director of kidney and pancreas transplantation at Northwestern University Feinberg School of Medicine. “With refinement, this approach may prove to be applicable to the majority of patients receiving the full spectrum of solid organ transplants.”

Leventhal authored the study along with Suzanne Ildstad, MD, director of the Institute of Cellular Therapeutics at the University of Louisville. It is the first study of its kind where the donor and recipient do not have to be related and do not have to be immunologically matched. Previous studies involving stem cell transplants for organ recipients have included donors and recipients who are siblings and are immunologically identical, something that only occurs in about 25 percent of sibling pairs.

“Being a transplant recipient is not easy. In order to prevent rejection, current transplant recipients must take multiple pills a day for the rest of their lives. These immunosuppressive medications come with serious side effects with prolonged use including high blood pressure, diabetes, infection, heart disease and cancer, as well as direct damaging effects to the organ transplant,” said Ildstad. “This new approach would potentially offer a better quality of life and fewer health risks for transplant recipients.”

In a standard kidney transplant, the donor agrees to donate their kidney. In the approach being studied, the individual is asked to donate part of their immune system as well. The process begins about one month before the kidney transplant, when bone marrow stem cells are collected from the blood of the kidney donor using a process called apheresis. The donor cells are then sent to the University of Louisville to be processed, where researchers enrich for “facilitating cells” believed to help transplants succeed. During the same time period, the recipient undergoes pre-transplant “conditioning,” which includes radiation and chemotherapy to suppress the bone marrow so the donor’s stem cells have more space to grow in the recipient’s body.

Once the facilitating cell-enriched stem cell product has been prepared, it is transported back to Northwestern, where the recipient undergoes a kidney transplant. The donor stem cells are then transplanted one day later and prompt stem cells to form in the marrow from which other specialized blood cells, like immune cells, develop. The goal is to create an environment where two bone marrow systems exist and function in one person. Following transplantation, the recipient takes anti-rejection drugs which are decreased over time with the goal to stop a year after the transplant.

New Transplant Method May Allow Kidney Recipients to Live Drug Free » Blog Archive » Critical Mass.

BI-STEM CELL SCIENTISTS and BLACK VATICAN EYES

In STEM CELLS IN THE NEWS on March 26, 2012 at 8:44 pm

“Bi-Stem Cell” describes a researcher who goes both ways; delving into the areas of both Adult and Embryonic…or maybe even iPSC if they are really open minded.  I did a quick check on the internet and I do believe I’ve coined this term.

 

Background: 

  1. The Vatican is pro-Adult stem cells first for religious reasons (based on the controversy associated with  Embryonic stem cells) and secondly because Adult stem cell treatments work and Embryonic do not (see Stem Cells 101).
  2. The Vatican publicizes a stem cell conference and invites two speakers who happen to research both Adult AND Embryonic stem cells.
  3. How should the Vatican handle these “bi-stem cell” speakers?

Now that we’re up to speed:

The Vatican  asked the two “bi-stem cell” speakers to only speak about Adult stem cells and they agreed. 

Imagine, you bring in speakers who ‘go both ways’ and get them to talk only about the benefits of going…one of the ways.  Their very silence on the subject of Embryonic stem cells is an indictment of Embryonic and an endorsement of Adult stem cells.  Not a bad plan if it works; but then…it all went sideways.  Apparently, the prelates raised concerns about how bi-stem cell scientists would confuse the masses, the conference was ultimately cancelled and now the Vatican public relations stem cell endeavor is tripping over its own feet. 

Conclusion:

Can science and religion peacefully co-exist? I don’t know…

but while this new ‘Black Vatican Eye’ is unfortunate, the real damage is to the millions of people who look to the Vatican for guidance in life and death decisions and will not see these two scientists extolling the proven virtues of the safety and therapeutic benefits of Adult stem cells. The ramification of this fumble effects not only the eternal souls of the churches members but also the extension of their health, longevity and quality of life AND the potential postponement of their deaths.

-David Granovsky

Canceled Stem Cell Conference is Another Black Eye for the Vatican

Vatican

Vatican (Photo credit: tejvanphotos)

I think the ghost of Teilhard de Chardin haunts the Vatican.

Whatever merits Pope Benedict deserves as a theologian, his papacy seems to be marked by one public relations debacle after another.

The latest black eye comes with the report this past Friday that the Pontifical Academy for Life is canceling a much publicized stem cell conference that was to take place next month, featuring (among many others) speakers like Douglas Melton and George Daley, leading researchers from the Harvard Stem Cell Institute.

The Third International Congress on Responsible Stem Cell Research was going to commence  at the Vatican on April 25th, for three days of presentations and discussion and to conclude with an audience with Pope Benedict XVI.

According to David Kerr’s report, one member of the Academy, who did not wish to be identified, had this to say: “I am infinitely relieved that the Church has avoided a major blunder which would have confused the faithful for decades to come.”

He then added, implausibly, “The Holy Spirit has certainly shown to be present through those faithful members who drew attention to the ambiguity of the choice of speakers. I hope and pray that a review will be affected of the basis on which these congresses are planned.”

As is well known, the Catholic Church is opposed to embryonic stem cell research, judging it as unethical because it involves the willful destruction of human embryos.

Melton and Daley conduct research using both embryonic and adult stem cells, but their agreement was to discuss only the latter at the conference…

Canceled Stem Cell Conference is Another Black Eye for the Vatican – Forbes.

TRAUMATIC BRAIN INJURY and STROKE

In DISEASE INFO on March 26, 2012 at 1:17 am

TO SEE IF YOU ARE A CANDIDATE FOR STEM CELL TREATMENT, PLEASE FILL OUT THE FOLLOWING FORM:  STEM CELL PATIENT QUESTIONNAIRE

I was told this was a con…here is my response:

My Stem Cells vs. Stroke page:
http://repairstemcell.wordpress.com/stroke-stem-cells/

Additional articles sorted by date (YEAR/MONTH/DAY):
http://repairstemcell.wordpress.com/2012/03/06/stem-cells-safe-for-young-traumatic-brain-injury/
http://repairstemcell.wordpress.com/2012/01/22/cellnews-scientists-learn-how-stem-cell-implants-help-heal-traumatic-brain-injury/

http://www.sciencedaily.com/releases/2011/08/110831160216.htm
http://repairstemcell.wordpress.com/2011/10/17/regenerating-the-central-nervous-system/

http://repairstemcell.wordpress.com/2010/09/20/stem-cell-treatment-for-stroke-and-traumatic-brain-injury-wholewellness-net/
http://repairstemcell.wordpress.com/2010/09/21/autologous-neural-stem-cells-benefit-parkinson%e2%80%99s-patients-adultstemcell-com/
http://repairstemcell.wordpress.com/2010/09/20/stem-cell-treatment-for-stroke-and-traumatic-brain-injury-wholewellness-net/
http://repairstemcell.wordpress.com/2010/08/28/cord-blood-wakes-up-drowning-victim%e2%80%99s-brain/
http://www.scientificamerican.com/article.cfm?id=can-stem-cells-block-stroke-damage
http://repairstemcell.wordpress.com/2010/07/12/stem-cell-gel-helps-repair-traumatic-brain-injuries-smartplanet/
http://www.scientificamerican.com/article.cfm?id=can-stem-cells-block-stroke-damage
http://repairstemcell.wordpress.com/2010/04/28/stem-cells-from-menstrual-blood-may-benefit-stroke-patients/

http://repairstemcell.wordpress.com/2009/04/20/stem-cell-research-shows-adult-stem-cells-help-stroke-victims-adult-stem-cell-research/
http://www.texmedctr.tmc.edu/root/en/TMCServices/News/2009/07-01/Stem+Cells+Tested+for+Treatment+of+Stroke.htm

A con? Ok my skeptical friends, I understand. You’ve been researching stroke treatments for so long and been so disheartened you don’t believe your condition can ever improve. You’ve read all the outdated literature saying the central nervous system can not regrow (except for the most recent studies which prove it can be.) You’ve skimmed my articles and realize they are uncorroborated by “hard science.”

Fair enough. Ignore the 14 articles above which show the positive benefits of adult stem cells on stroke. You’re right, they are unsubstantiated. They are not peer reviewed medical journal articles. I appreciate your skepticism but know this:

*there are over 2,600 peer reviewed medical journal clinical trials that utilized adult stem cells with a record of safety and efficacy,
*there are many trials that cover the use of adult stem cells for stroke, ataxia, TBI, etc
*there are 60 trials that have the key words “adult stem cell” and “stroke.”
*there are 14 “Completed” trials that have the key words “adult stem cell” and “stroke.”

Research it yourself if you like. http://clinicaltrials.gov/ct2/results?term=adult+stem+cell+stroke&pg=1&show_flds=Y

Here are only the 14 “completed” trials:

Completed Efficacy Study of CD34 Stem Cell in Chronic Stroke Patients

Conditions: Stroke;   Middle Cerebral Artery Infarction
Interventions: Procedure: Intercerebral implantation of Autulogous Stem Cells;   Drug: convention therapy
Completed Intravenous Autologous Bone Marrow-derived Stem Cells Therapy for Patients With Acute Ischemic Stroke

Condition: Acute Stroke
Intervention: Biological: Autologous bone marrow stem cell
Completed Autologous Bone Marrow Stem Cells in Middle Cerebral Artery Acute Stroke Treatment.

Conditions: Stroke, Acute;   Infarction, Middle Cerebral Artery
Intervention: Procedure: Infusion on autologous CD34+ stem cells into middle cerebral artery
Completed Study of Autologous Stem Cell Transplantation for Patients With Ischemic Stroke

Condition: Infarction, Middle Cerebral Artery
Intervention: Other: Autologous cell transplantation
21 Completed Granulocyte-colony Stimulating Factor for Stem Cells Therapy for Acute Ischemic Stroke

Condition: Ischemic Stroke
Intervention: Drug: Filgrastim
31 Completed Sickle Cell Disease and Endothelial Progenitor Cells (EPCs)

Condition: Sickle Cell Anemia
Intervention: Procedure: Angiography
34 Completed Investigating Endothelial Precursor Cells (EPCs)

Condition: Central Nervous System
Intervention:
38 Completed Immunological Mechanisms of Hematopoietic Stem Cell Transplantation in Multiple Sclerosis

Condition: Multiple Sclerosis
Intervention: Procedure: Stem Cell Transplanataion
40 Completed Gene Therapy for Gaucher’s and Fabry Disease Using Viruses and Blood-Forming Cells

Condition: Gaucher’s Disease
Intervention: Genetic: human glucocerebrosidase cDNA
51 Completed Single-Dose Pharmacokinetics (PK) Study of Novel Neurogenic Compound NSI-189

Condition: Depression
Intervention: Drug: NSI-189 Phosphate
52 Completed Beta-hCG + Erythropoietin in Acute Stroke

Condition: Acute Stroke
Intervention: Drug: Beta-hCG + Erythropoietin
54 Completed Effects of Hyperbaric Oxygen Therapy in Autistic Children: A Pilot Study

Conditions: Autism;   Oxidative Stress;   Inflammation
Intervention: Drug: Hyperbaric Oxygen Therapy
59 Completed Effects of Enzyme Replacement in Gaucher’s Disease

Condition: Gaucher’s Disease
Intervention:
60 Completed Incidence of Ocular Antibodies in Patients With Sturge – Weber Syndrome (SWS)

Condition: Sturge – Weber Syndrome (SWS)
Intervention:

 

 

If you still feel this is a con, tell me what you would need to see to prove otherwise. Respectfully, David

FDA’s New Claim: “Your Body Is a Drug—and We Have the Authority to Regulate It!” | The Alliance for Natural Health USA

In BUSINESS OF STEM CELLS on March 21, 2012 at 4:27 am
FDA’s New Claim: “Your Body Is a Drug—and We Have the Authority to Regulate It!”

January 31, 2012

stem cellIn another outrageous power-grab, FDA says your own stem cells are drugs—and stem cell therapy is interstate commerce because it affects the bottom line of FDA-approved drugs in other states!

 

We wish this were a joke, but it’s the US Food and Drug Administration’s latest claim in its battle with a Colorado clinic over its Regenexx-C™ procedure, a non-surgical treatment for people suffering from moderate to severe joint or bone pain using adult stem cells.

The FDA asserts in a court document that it has the right to regulate the Centeno-Schultz Medical Clinic for two reasons:

  1. Stem cells are drugs and therefore fall within their jurisdiction. (The clinic argues that stem cell therapy is the practice of medicine and is therefore not within the FDA’s jurisdiction!)
  2. The clinic is engaging in interstate commerce and is therefore subject to FDA regulation because any part of the machine or procedure that originates outside Colorado becomes interstate commerce once it enters the state. Moreover, interstate commerce is substantially affected because individuals traveling to Colorado to have the Regenexx procedure would “depress the market for out-of-state drugs that are approved by FDA.”

 

We discussed the very ambiguous issue of interstate commerce last September—it’s an argument the FDA frequently uses when the basis for their claim is otherwise lacking. As we noted then, the FDA holds that an “interstate commerce” test must be applied to all steps in a product’s manufacture, packaging, and distribution. This means that if any ingredient or tool used in the procedure in question was purchased out of state, the FDA would in its view have jurisdiction, just as they would if the final product had traveled across state lines.

 

This time the FDA just nakedly says in court documents that the agency wants to protect the market for FDA-approved drugs. No more beating around the bush—their agenda is right out in the open! This appears to be a novel interpretation of the Food Drug and Cosmetic Act (FD&C), as evidenced by the government’s failure to cite any judicial precedent for their argument.

 

The implication of the FDA’s interpretation of the law, if upheld by the court, would mean that all food, drugs, devices, and biologic or cosmetic products would be subject to FDA jurisdiction. The FDA is expanding its reach even to commerce within the state, which we argue is far beyond its jurisdiction, in order to protect drug company profits.

 

Last year we ran a two-part series on the current status of federal and state law—and FDA jurisdiction—and how it affects integrative treatments (part one and part two).

 

The Centeno-Schultz Medical Clinic takes your blood and bone marrow, puts it into a centrifuge machine that separates the stem cells, and cultures it to get more cells before a doctor puts them back in your body to repair damaged tissue. The FDA states that when the stem cells are cultured, they become FDA-regulated drugs. The clinic has argued numerous times that stem cells aren’t drugs because they are components of the patient’s bone marrow from his or her own body.

 

The FDA says otherwise: “Stem cells, like other medical products that are intended to treat, cure, or prevent disease, generally require FDA approval before they can be marketed. At this time, there are no licensed stem cell treatments.” There they go again, saying that components of your body are drugs and they have the authority to regulate them! It’s the only way the agency can claim that adult stem cell therapy is within FDA’s purview.

 

However, the agency seems to be of two minds. When ESPN magazine was doing a story on stem cell treatments, the FDA stated that US policy is to allow the injection of stem cells that are treated with “minimal manipulation,” which federal regulations define as “processing that does not alter the relevant biological characteristics of cells or tissues”—which is certainly the case with the Regenexx same-day procedure.

 

Despite this policy, FDA has been attacking the clinic for the past four years. They have tried injunctions and demanded inspections in their attempts to make the company bend; this court battle is merely the latest salvo.

 

The primary role of adult stem cells in a living organism is to maintain and repair the tissue in which they are found. The hard part has been to get enough of them. But new technology is giving doctors the ability to obtain more stem cells from a patient than previously thought possible, which is why we’re now seeing new treatments. Blood, fat, or tissue is withdrawn from the patient, stem cells are obtained using one of these new processes, and the cells are injected back into the patient where they can repair the patient’s tissue.

 

Gov. Rick Perry received this kind of stem cell therapy. We and others noted that the governor’s defense of freedom of healthcare choice when it came to his own treatment was starkly at odds with his directive to administer HPV vaccines to young girls against their own (and their parents’) wishes. It’s also at odds with his support for some of the most egregious witch-hunters on the Texas State Medical Board, which he appoints.

 

 

 

Behind Perry’s blatant inconsistency and the latest FDA attempted power grab lies the same problem: a medical system run by special interests under the leadership of the US government, the same government that is supposed to represent “we the people.”

Editors’ Note: An earlier version of this article reported that when blood and bone marrow were put into a centrifuge to separate the stem cells, the FDA considered the stem cells to be a drug and claimed authority to regulate them. The article has been updated to reflect that FDA only claims authority to regulate as drugs those stem cells which are cultured before being re-injected into the body.

 

FDA’s New Claim: “Your Body Is a Drug—and We Have the Authority to Regulate It!” | The Alliance for Natural Health USA.

 

Related commentary: ABORTION, EMBRYONIC STEM CELLS, CRICHTON and PHARMA:
insidious analysis…i been around the block once or twice and traveled and listened enough to know that things are not always what they seem and the reasons for doing so are rarely what they appear.

women’s rights are getting squeezed and rung out of them like yesterday’s dirty sponge water and while this is a travesty in and of itself I can’t help but believe that this is the beginning of many more injustices and changes which will make our heads spin. is this an effort to establish that: your body is not your own? we no longer have the right to choose what we put in our body (from vaginal probes to GMOs so “my body/their property” seems closer than i care to admit…

For an absolutely chilling account of “My Bodies, Their Property” read this:

“Patenting lives: life patents, culture and development” Forfeited Consent: Body parts in Eminent Domain Page 95 http://books.google.com/books?id=3hFLooYJRIcC&printsec=frontcover
“Intellectual property, medicine and health: current debates” Property and Human Tissue Page 123 http://books.google.com/books?id=ZIaM8LXlGG0C&printsec=frontcover

Basically, if a woman is state or corporate property, then so is her fetal matter; so doctors can remove the biological materials and use it with legal backing? OR, if a woman is genetically resistant to a specific disease, maybe they can just claim her child and use it for testing?

more and more i see actions performed under the umbrella excuse “the good of the many outweighs the needs of the few” How long before the health of the many is worth the death of the one? perhaps this an embryonic stem cell angle? one last gasp of pharma to fool the public into carrying the embryonic stem cell torch despite the FACT that embryonic stem cell treatments don’t work and do cause tumors?

this isn’t out of the realm of reality, if you disbelieve, go read Mike Chrichton’s 2006 book NEXT – “…and that the physician’s university had sold the rights in Frank’s cells to BioGen, a biotechnology startup company. As the book opens Frank is suing the university for unauthorized misuse of his cells, but the trial judge rules that the cells were “waste” that the university could dispose of as it wished. Frank’s lawyers advise that, even if he wins an appeal, the university as a tax-funded organization can still claim the rights to the cells under the doctrine of eminent domain.”

The pharma company then goes after his kids since the genetic material is the same and if they own the father, the own the son (and the sins of the father shall be visited on the sons…the genetic commercial potential tool) M.C. said about this book: “This novel is fiction, except for the parts that aren’t.”

We’ll see…this goes in the category of “i hope i’m wrong but this twisting in my gut is telling me otherwise”

Search and Rescue Dog in 9/11 Attacks Receives Stem Cell Treatment in Burke – Lorton, VA Patch

In STEM CELLS IN THE NEWS on March 20, 2012 at 3:12 am

Search and Rescue Dog in 9/11 Attacks Receives Stem Cell Treatment in Burke

Treatment should help alleviate aches and pains for “Red,” a 12-year-old black Labrador retriever.

 March 19, 2012

    

 

A decade ago, “Red,” a black Labrador search and rescue dog, was deployed in the 9/11 attacks at the Pentagon in Arlington.

Many of the hundreds of search and rescue dogs sent to the Pentagon, World Trade Center in New York City and Shanksville, Pa., have since passed away.

On Monday, Red, who is now 12 years old, received a breakthrough stem cell regenerative treatment from Dr. John Herrity, D.V.M., at the Burke Animal Clinic to help ease crippling arthritis and live out her days in greater comfort.

Red was sent to the Pentagon on Sept. 16, 2001, with her owner and handler, Heather Roche of Annapolis, Md. They worked at the site for 11 days, finding remains of victims in the Pentagon’s north parking-lot area. Red later helped in the aftermath of Hurricanes Katrina and Rita.

No longer able to handle tasks like climbing a two-story ladder, Red retired in July 2011. “She still wants to work, but her body just can’t do it anymore,” Roche said.

“This dog gave a lot to us,” Herrity said Monday afternoon after performing the treatment on Red. “They do searches for remains in burned out buildings. It’s the least we can do for these guys.”

Procedure Lets Old Dogs Run, Play Again

The two-part procedure takes a little over an hour and normally costs $2,000 to $2,400. Two other 9/11 dogs that recently received the same stem cell therapy are able to run, climb and play again. The treatment mainly helps larger breed dogs ages 9 and older with hip and arthritis problems.

Herrity has experience with more than two-dozen stem cell operations. MediVet-America, which developed the in-clinic stem cell technology, donated the cost of the procedure and cryogenic banking of additional stem cells.

Veterinarians and researchers describe stem cell regenerative therapy as a major scientific development in the treatment of arthritis, hip dysplasia, ligament and cartilage injuries and other degenerative joint diseases in dogs, cats, horses and other animals. The technology uses an adult animals’ own stem cells to heal itself.

MediVet-America’s treatment involves removing fat tissue from the animal, separating the stem cells from the fat, activating and injecting the cells into the affected areas. Within four to six weeks, animals who were in severe pain with a restricted range of motion are able to walk, run and even jump again. Key to the procedure is an advanced, patented L.E.D. technology that activates millions of dormant stem cells present in fat tissue.

MediVet donated the test kit system for Red’s procedure on Monday.

Two other Sept. 11 search and rescue dogs also have been treated with stem cell therapy and are doing well, according to MediVet. Bailey, a 15 year-old black Lab, underwent the procedure in November. Hoke, a 14 year-old yellow Lab, was treated in December. Both are doing well, according to their handlers, and have resumed normal activity in retirement.

“We are proud to help the unsung canine heroes of 9/11 more than a decade after the attacks,” said MediVet-America CEO Jeremy Delk. “They deserve the very best stem cell therapeutic care that is now being received by animals across the nation.”

Herrity said the recovery process takes about two to three months. “Our society today wants everything done yesterday,” he said. “But that’s not how the body works.”

 

Search and Rescue Dog in 9/11 Attacks Receives Stem Cell Treatment in Burke – Lorton, VA Patch.

ABORTION, EMBRYONIC STEM CELLS, CRICHTON and PHARMA

In ALL ARTICLES on March 19, 2012 at 2:03 am
ABORTION, EMBRYONIC STEM CELLS, CRICHTON and PHARMA:
insidious analysis…i been around the block once or twice and traveled and listened enough to know that things are not always what they seem and the reasons for doing so are rarely what they appear.

women’s rights are getting squeezed and rung out of them like yesterday’s dirty sponge water and while this is a travesty in and of itself I can’t help but believe that this is the beginning of many more injustices and changes which will make our heads spin. is this an effort to establish that: your body is not your own? we no longer have the right to choose what we put in our body (from vaginal probes to GMOs so “our bodies/your property” seems closer than i care to admit…

For an absolutely chilling account of “Our Bodies, Your Property” read this:

Basically, if a woman is state or corporate property, then so is her fetal matter; so doctors can remove the biological materials and use it with legal backing? OR, if a woman is genetically resistant to a specific disease, maybe they can just claim her child and use it for testing?

more and more i see actions performed under the umbrella excuse “the good of the many outweighs the needs of the few” How long before the health of the many is worth the death of the one? perhaps this an embryonic stem cell angle? one last gasp of pharma to fool the public into carrying the embryonic stem cell torch despite the FACT that embryonic stem cell treatments don’t work and do cause tumors?

this isn’t out of the realm of reality, if you disbelieve, go read Mike Chrichton’s 2006 book NEXT – “…and that the physician’s university had sold the rights in Frank’s cells to BioGen, a biotechnology startup company. As the book opens Frank is suing the university for unauthorized misuse of his cells, but the trial judge rules that the cells were “waste” that the university could dispose of as it wished. Frank’s lawyers advise that, even if he wins an appeal, the university as a tax-funded organization can still claim the rights to the cells under the doctrine of eminent domain.”

The pharma company then goes after his kids since the genetic material is the same and if they own the father, the own the son (and the sins of the father shall be visited on the sons…the genetic commerical potential tool) M.C. said about this book: “This novel is fiction, except for the parts that aren’t.”

We’ll see…this goes in the category of “i hope i’m wrong but this twisting in my gut is telling me otherwise”

Granovsky Palace…who knew?

In STEM CELLS IN THE NEWS on March 10, 2012 at 2:15 am
Granovsky Palace…I never even knew I was royalty, much less Czechoslovakian royalty. The things you find unexpectedly on the internet. :)

Renaissance Granovsky Palace

The most interesting building in the Tyn courtyard is the Granovsky Palace, one of the Renaissance pearls of Prague. This house from 1558 is decorated with sgraffitoes and wall paintings and it has an arcade loggia. The paintings on the loggia depict scenes from Bible and Greek mythology. via

The road leads through a small, arched tunnel and onto Ungelt courtyard. Here you can stop for a cup of coffee at Ebel’s outdoor café, admire the refurbished murals and arches of Granovsky Palace and imagine how it must have been in the 11th century when the area was a closed yard for collecting duties on traded goods, hence the name “Un-gelt.” via http://www.prague-tourist.com/6.php

via http://www.pbase.com/byrontilly/image/63729222

via http://lostandfoundinprague.tumblr.com/post/20480085147/granovsky-palace-in-prague-photo-by-josef-ehm

FRESCOES – via http://judkins71.blogspot.com/2010/07/renaissance-in-prague-june-30.html (lots more pics on this site with some silly banter)

Stem Cells Safe for Young Traumatic Brain Injury

In SCIENCE & STEM CELLS on March 6, 2012 at 4:02 am
Image showing potential uses of stem cell research with traumatic brain injuries checked.
A Phase 1 clinical trial studying the safety of using bone marrow stem cells to treat traumatic brain injuries in children is reported. The procedures look to be safe even after 6 months of being applied. The image is adapted from a public domain image

Bone Marrow Stem Cells Safe for Young Traumatic Brain Injury Patients

Saturday March 3rd 2012

A procedure involving stem cells taken from patients’ own bone marrow to treat traumatic brain injury in children is safe, according to the results of a Phase 1 clinical trial.

The trial included 10 children aged 5-14 with severe traumatic brain injuries. Within 48 hours of their injuries, the children received stem cells processed from their own bone marrow.

Six months following the procedures, the children are showing no signs of further damage caused by the use of the stem cells. Though this study only points out that the procedure is safe so far, all of the children from the study had significant improvements.

Stem cell research studies such as this one are producing more and more evidence that stem cell treatments can be safe and effective.

With very few effective treatments for brain injury patients, these studies provide great promise for the future of medicine.

The University of Texas Health Science Center at Houston press release below offers more details about this and other stem cell studies.

UTHealth study: Stem cells may provide treatment for brain injuries

Preliminary results show safety of bone marrow stem cells in traumatic brain injury

Stem cells derived from a patient’s own bone marrow were safely used in pediatric patients with traumatic brain injury (TBI), according to results of a Phase I clinical trial at The University of Texas Health Science Center at Houston (UTHealth). The results were published in this month’s issue of Neurosurgery, the journal of the Congress of Neurological Surgeons.

“Our data demonstrate that the acute harvest of bone marrow and infusion of bone marrow mononuclear cells to acutely treat severe TBI in children is safe,” said Charles S. Cox, Jr., M.D., the study’s lead author and professor of pediatric neurosurgery at the UTHealth Medical School. The clinical trial, which included 10 children aged 5 to 14 with severe TBI, was done in partnership with Children’s Memorial Hermann Hospital, where Cox is director of the pediatric trauma program.

All the children were treated within 48 hours of their injury with their own stem cells, which were collected from their bone marrow, processed and returned to them intravenously. UTHealth’s Department of Neurology is also currently testing the same bone marrow stem cell procedure in adults with acute stroke. In a separate trial, Cox is testing the safety of using a patient’s own cord blood stem cells for traumatic brain injury in children.

As a Phase I trial designed to look at feasibility and safety, the study did not assess efficacy. However, after six months of follow-up, all of the children had significant improvement and seven of the 10 children had a “good outcome,” meaning no or only mild disability.

Children who survive severe TBI are often left with serious complications and disability. Currently, there are no effective treatments to protect or promote repair of the brain in these brain-injured children.

Read more: Bone Marrow Stem Cells Safe for Young Traumatic Brain Injury Patients | Neuroscience News.

Ethan Zohn undergoes stem-cell transplant

In VICTORIES & SUCCESS STORIES on March 5, 2012 at 4:04 am

Ethan Zohn undergoes stem-cell transplant, thanks ‘Survivor’ girlfriend Jenna Morasca

His fighting spirit, family & friends keep him positive

By Joyce Chen / NEW YORK DAILY NEWS
Thursday, March 1, 2012, 4:39 PM

 	Ethan Zohn had a stem-cell transplant to treat his Hodgkin’s lymphoma.

Rob Loud/Getty Images

Ethan Zohn had a stem-cell transplant to treat his Hodgkin’s lymphoma.

Ethan Zohn is by all measures the definition of a true survivor.

The former “Survivor” winner underwent a stem-cell transplant Wednesday to treat his recurring case of Hodgkin’s lymphoma, and even under the serious circumstances, Zohn still had competition on his mind.

“Ethan asked the doctor what was the record time for getting out of here, so he wants to beat that,” Zohn’s longtime girlfriend Jenna Morasca told People.

“His doctor said there was no prize, and Ethan said, ‘Yes, there is. You’re going to tell the other patients that I made it out in three weeks.’”…

Read more: Ethan Zohn undergoes stem-cell transplant, thanks ‘Survivor’ girlfriend Jenna Morasca – NY Daily News.

Follow

Get every new post delivered to your Inbox.

Join 2,984 other followers

%d bloggers like this: